DRUG ELUTING BALLOON MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America remains the dominant region in the global drug eluting balloon market and is estimated to hold 43.9% of the market share in 2024 due to  high healthcare expenditure, presence of leading players and adoption of advanced technologies at faster pace in countries like U.S. and Canada. Rising prevalence of cardiovascular diseases in North America contributes to larger patient pool undergoing angioplasty procedures, where drug eluting balloons are widely used. North America is an attractive base for many international players to set up manufacturing facilities due to availability of key resources and skilled workforce.

One of the fastest growing regions for drug eluting balloon market is Asia Pacific excluding Japan (APEJ). The growth can be attributed to rising healthcare infrastructure, growing medical tourism industry and increasing disposable incomes in developing economies like China and India. Both China and India have a huge population base with growing disease burdens and rising cases of lifestyle diseases. This serves as a huge patient pool and potential market for all medical devices including drug eluting balloons. Additionally, many Asian countries are focusing on enhancing healthcare access through various governmental initiatives, and this boosts demand for cost-effective treatment alternatives like drug eluting balloons.